Global anti-malarial drugs market size was valued at US$ 740 Mn in 2017 and is expected to reach US$ 1012 Mn by 2026 to exhibit a CAGR of 3.99 % during a forecast period. Global Anti-malarial drugs market Anti-malarial drugs are the medicines used to prevent as well as treat malaria. They are also used for avoidance of infection in individuals who travel to malaria-endemic regions. Malaria is a life-threatening disease caused by parasites that are spread toward people through the bites of infected female Anopheles mosquitoes.
Malaria is preventable and curable. Anti-malarial medicines are available in the market in the form of tablet, injectables, and capsules. The strong initiatives taken by the various state governments and governing bodies such as U.
S. food and drug administration (FDA) to reduce the occurrence of malarial disease throughout the world, also estimated to fuel the demand for the anti-malarial drugs market. Availability of key players, and better R&D facilities & reimbursement policies are the major factors driving the growth of the global anti-malarial drugs market. However, the possible side effects of anti-malarial drugs like insomnia, vivid dreams, mental clouding, dizziness, and anxiety may hinder the growth of the global anti-malarial drugs market. Malaria is considered as a most terrible disease because it causes of death due to lack of availability of the anti-malarial drugs which has become the key opportunity for the growth of the anti-malarial drugs market during the forecast period. There are four major drugs, which currently used to treat malaria include quinoline-related compounds, antifolates, artemisinin derivatives, and antimicrobials.
Quinine is a medicine used to treat malaria and babesiosis. Quinine contains the treatment of malaria, owing to Plasmodium falciparum that is resistant to chloroquine when artesunate is not available. Artemisinin is used to reduce the number of Plasmodium parasites in the blood of patients with malaria.
Some side effects of artemisinin include skin rash, nausea, vomiting, tremors, and liver issues. Plasmodium falciparum and Plasmodium vivax are the most dangerous types of malaria. Plasmodium falciparum is the most common malaria parasite in South Africa, and it causes the most malaria-related deaths in the world.
Plasmodium falciparum multiplies very quickly and causing severe blood loss as well as clogged blood vessels. Plasmodium vivax is mostly found in the Asia Pacific. Plasmodium vivax infects 19-50 million people with malaria every year.
Asia-Pacific is the most lucrative region for the anti-malarial drugs, owing to the higher incidence of the malarial diseases in the region and thus is expected to show a robust growth to the global anti-malarial drugs market. The Asia Pacific is account for the highest market share of 30.2% during the forecast For More Information Visit:https://www.maximizemarketresearch.com/market-report/global-acetone-market/24979/ This Report Is Submitted By @Global Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact Us: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH Email: email@example.com Contact: +91 9607365656.